Evidence map›Paper›PMID 26626495›Full record

ArticleJournal of hepatology2016

Liver transplant center variability in accepting organ offers and its impact on patient survival.

David S Goldberg, Benjamin French, James D Lewis, Frank I Scott, Ronac Mamtani, Richard Gilroy, Scott D Halpern, Peter L Abt

Abstract read
In one paragraph

Article in Journal of hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Referral to Liver Transplant: A National Survey from Portugal.GE Portuguese journal of gastroenterology · 2025
    Article
  3. Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. The evolution of the liver transplant candidate.Frontiers in transplantation · 2023
    Review
  8. Article
  9. Risk Aversion, Organ Utilization and Changing Behavior.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Article
  10. Article
  11. Article
  12. Center variation in long-term outcomes for socioeconomically deprived children.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  13. Review
  14. RELATIONSHIP BETWEEN DONOR QUALITY AND RECIPIENT GRAVITY IN LIVER TRANSPLANT.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2020
    Article
  15. Article
  16. Article
  17. Variability in donor organ offer acceptance and lung transplantation survival.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2020
    Article
  18. Tool to Aid Patients in Selecting a Liver Transplant Center.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2020
    Article
  19. Article
  20. Geographic disparities in liver supply/demand ratio within fixed-distance and fixed-population circles.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

David S GoldbergDivision of Gastroenterology, Department of Medicine, University of Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, USA. Electronic address: david.goldberg@uphs.upenn.edu.
Benjamin FrenchCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, USA.
James D LewisDivision of Gastroenterology, Department of Medicine, University of Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, USA.
Frank I ScottDivision of Gastroenterology, Department of Medicine, University of Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA.
Ronac MamtaniDivision of Hematology and Oncology, Department of Medicine, University of Pennsylvania, USA.
Richard GilroyDivision of Gastroenterology, Department of Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
Scott D HalpernCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, USA; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, USA.
Peter L AbtDivision of Transplantation, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Funding

Insulin resistance in the development and progression of invasive bladder cancerK23CA187185 · NCI · UNIVERSITY OF PENNSYLVANIA · PI MAMTANI, RONAC · 2015 to 2019
$872k
A population-based cohort to study outcomes in end-stage liver disease patientsK08DK098272 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GOLDBERG, DAVID SETH · 2013 to 2017
$786k
Microvascular disease, statins, ACE-inhibitors and post-operative SBOK08DK095951 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SCOTT, FRANK IRVING · 2012 to 2016
$771k
NCI NIH HHS K23 CA187185NIDDK NIH HHS K08 DK095951NIDDK NIH HHS K08 DK098272PHS HHS 234-2005-37011C
6 · The paper itself

Abstract

BACKGROUND &

aimsDespite an allocation system designed to give deceased-donor livers to the sickest patients, many transplantable livers are declined by U.S. transplant centers. It is unknown whether centers vary in their propensities to decline organs for the highest priority patients, and how these decisions directly impact patient outcomes.

methodsWe analyzed Organ Procurement and Transplantation Network (OPTN) data from 5/1/07-6/17/13, and included all adult liver-alone waitlist candidates offered an organ that was ultimately transplanted. We evaluated acceptance rates of liver offers for the highest ranked patients and their subsequent waitlist mortality.

resultsOf the 23,740 unique organ offers, 8882 (37.4%) were accepted for the first-ranked patient. Despite adjusting for organ quality and recipient severity of illness, transplant centers within and across geographic regions varied strikingly (p<0.001) in the percentage of organ offers they accepted for the highest priority patients. Among all patients ranked first on waitlists, the adjusted center-specific organ acceptance rates ranged from 15.7% to 58.1%. In multivariable models, there was a 27% increased odds of waitlist mortality for every 5% absolute decrease in a center's adjusted organ offer acceptance rate (adjusted OR: 1.27, 95% CI: 1.20-1.32). However, the absolute difference in median 5-year adjusted graft survival was 4% between livers accepted for the first-ranked patient, compared to those declined and transplanted at a lower position.

conclusionThere is marked variability in center practices regarding accepting livers allocated to the highest priority patients. Center-level decisions to decline organs substantially increased patients' odds of dying on the waitlist without a transplant.

Indexed as

Tissue and Organ ProcurementFemaleHumansLiver TransplantationMaleMiddle AgedSeverity of Illness IndexWaiting ListsDeclineOrgan offerWaitlist mortality

Identifiers

PMID26626495
PMCPMC4799773

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.